Gene · 6752
Papers3,968
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
821 to 840 of 3,968
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Protein and Gene Delivery Systems for Neurodegenerative Disorders: Where Do We Stand Today? | Pharmaceutics | 2022 | 36365243 | PubTator, text mining | PubMed |
| Peptide-Drug Conjugates: A New Hope for Cancer Management. | Molecules | 2022 | 36364057 | PubTator, text mining | PubMed |
| Current Concepts and Future Applications of Non-Invasive Functional and Anatomical Evaluation of Coronary Artery Disease. | Life (Basel) | 2022 | 36362957 | PubTator, text mining | PubMed |
| Co-Expression of Adaptor Protein FAM159B with Different Markers for Neuroendocrine Cells: An Immunocytochemical and Immunohistochemical Study. | Int J Mol Sci | 2022 | 36362289 | PubTator, text mining | PubMed |
| Somatostatin, Cortistatin and Their Receptors Exert Antitumor Actions in Androgen-Independent Prostate Cancer Cells: Critical Role of Endogenous Cortistatin. | Int J Mol Sci | 2022 | 36361790 | PubTator, text mining | PubMed |
| Development of Human Pituitary Neuroendocrine Tumor Organoids to Facilitate Effective Targeted Treatments of Cushing's Disease. | Cells | 2022 | 36359740 | PubTator, text mining | PubMed |
| Evaluation of 68Ga-Radiolabeled Peptides for HER2 PET Imaging. | Diagnostics (Basel) | 2022 | 36359554 | PubTator, text mining | PubMed |
| Approach of Acromegaly during Pregnancy. | Diagnostics (Basel) | 2022 | 36359512 | PubTator, text mining | PubMed |
| The Glasgow Prognostic Score Predicts Survival Outcomes in Neuroendocrine Neoplasms of the Gastro-Entero-Pancreatic (GEP-NEN) System. | Cancers (Basel) | 2022 | 36358883 | PubTator, text mining | PubMed |
| Mind the Gap-Deciphering GPCR Pharmacology Using 3D Pharmacophores and Artificial Intelligence. | Pharmaceuticals (Basel) | 2022 | 36355476 | PubTator, text mining | PubMed |
| Head-to-Head Comparison between Peptide-Based Radiopharmaceutical for PET and SPECT in the Evaluation of Neuroendocrine Tumors: A Systematic Review. | Curr Issues Mol Biol | 2022 | 36354685 | PubTator, text mining | PubMed |
| Reporter Transgenes for Monitoring the Antitumor Efficacy of Recombinant Oncolytic Viruses. | Acta Naturae | 2022 | 36348722 | PubTator, text mining | PubMed |
| Learn from antibody-drug conjugates: consideration in the future construction of peptide-drug conjugates for cancer therapy. | Exp Hematol Oncol | 2022 | 36348391 | PubTator, text mining | PubMed |
Response to targeted radionuclide therapy with [131I]MIBG AND [177Lu]Lu-DOTA-TATE according to adrenal vs. extra-adrenal primary location in metastatic paragangliomas and pheochromocytomas: A systematic review. | Front Endocrinol (Lausanne) | 2022 | 36339441 | PubTator, text mining | PubMed |
| Metabolomic, Lipidomic, Transcriptomic, and Metagenomic Analyses in Mice Exposed to PFOS and Fed Soluble and Insoluble Dietary Fibers. | Environ Health Perspect | 2022 | 36331819 | PubTator, text mining | PubMed |
| The past, present, and future physiology and pharmacology of glucagon. | Cell Metab | 2022 | 36323234 | PubTator, text mining | PubMed |
| Identification of MRAP protein family as broad-spectrum GPCR modulators. | Clin Transl Med | 2022 | 36314066 | PubTator, text mining | PubMed |
| Case report: Use of 68Ga-DOTATATE-PET for treatment guidance in complex meningioma disease. | Front Oncol | 2022 | 36313670 | PubTator, text mining | PubMed |
| Integrated proteogenomic characterization across major histological types of pituitary neuroendocrine tumors. | Cell Res | 2022 | 36307579 | PubTator, text mining | PubMed |
| Cancer cells can be killed mechanically or with combinations of cytoskeletal inhibitors. | Front Pharmacol | 2022 | 36299893 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6752/papers?page=42